ReviewThe British journal of radiology2021
Differentiating uterine sarcoma from leiomyoma: BET
Review in The British journal of radiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.
- ESR Essentials: uterine cancers-practice recommendations by the European Society of Urogenital Radiology.European radiology · 2026Guideline
- Uterine mesenchymal tumors: development and preliminary results of a magnetic resonance imaging (MRI) diagnostic algorithm.La Radiologia medica · 2023Trial
- Diagnostic Performance of Galectin-1 and Mucin-1 in Uterine Tumors: A Case-Control Study.Current issues in molecular biology · 2026Article
- Rare and uncommon tumours of the female pelvis: what the radiologist should know.The British journal of radiology · 2026Review
- Article
- Development of a blood test for uterine sarcoma-Diagnosis and monitoring (DOORS-D and DOORS-M) studies.PloS one · 2026Article
- Preoperative differential diagnosis - uterine sarcoma or myoma?Przeglad menopauzalny = Menopause review · 2025Review
- Uterine Stroma-Derived Tumors and the Extracellular Matrix: A Comparative Review of Benign and Malignant Pathologies.Cancers · 2025Review
- Tissue-Specific Genomic Evolution Despite Shared MED12 Mutations in Benign Tumors.Journal of clinical medicine · 2025Article
- Challenges in Diagnosing Uterine Leiomyosarcoma in Pregnancy: A Case Report and Lessons Learned.Cureus · 2025Article
- Diagnostic and surgical management of giant broad ligament myoma with cystic degeneration: A case report.World journal of clinical cases · 2025Article
- Challenges in Differentiating Uterine Mesenchymal Tumors-Key Diagnostic Criteria.Journal of clinical medicine · 2025Review
- Increasing Awareness of Soft-Tissue Sarcoma: Podcast of a Patient-HCP Discussion.Oncology and therapy · 2025Article
- Artificial Intelligence and Uterine Fibroids: A Useful Combination for Diagnosis and Treatment.Journal of clinical medicine · 2025Review
- Article
- Preoperative identification from occult leiomyosarcomas in laparoscopic hysterectomy and laparoscopic myomectomy: accuracy of the ultrasound scoring system (PRESS-US).La Radiologia medica · 2024Article
- Metastatic malignant peripheral nerve sheath tumor of the uterus and cervix: Diagnostic Challenges, prognostic determinants and treatment.Gynecologic oncology reports · 2024Article
- Article
- Smooth muscle tumours of the uterus: MR imaging malignant predictive features-a 12-year analysis in a referral hospital in Portugal.Archives of gynecology and obstetrics · 2024Article
- Breast lump as the initial presentation of metastatic uterine leiomyosarcoma: a case report and comprehensive literature review.Croatian medical journal · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although rare, uterine sarcoma is a diagnosis that no one wants to miss. Often benign leiomyomas (fibroids) and uterine sarcomas can be differentiated due to the typical low T2 signal intensity contents and well-defined appearances of benign leiomyomas compared to the suspicious appearances of sarcomas presenting as large uterine masses with irregular outlines and intermediate T2 signal intensity together with possible features of secondary spread. The problem is when these benign lesions are atypical causing suspicious imaging features. This article provides a review of the current literature on imaging features of atypical fibroids and uterine sarcomas with an aide-memoire BET
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.